D

Deepa Jonnalagadda

Sanford Burnham Prebys Medical Discovery Institute

ORCID: 0000-0002-1511-8197

26 papers and 1.4k citations.

PubIndex Score80Top 20% · early-careerHow it's scored

26Publications

1.4kTotal Citations

First publication: 2009First senior author: 2013

Top publicationsby citations

Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders

Jerold Chun, Victoria A. Blaho, Yasuyuki Kihara et al.|The Annual Review of Pharmacology and Toxicology|2019

Cited by 128

A Functionally Defined <i>In Vivo</i> Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (<i>ieAstrocytes</i>)

Aran Groves, Jerold Chun, Yasuyuki Kihara et al.|eNeuro|2018

Cited by 57

FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis

Deepa Jonnalagadda, Jerold Chun|Cell Reports|2023

Cited by 16

Lysophospholipid (LPA) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Victoria A. Blaho, Yun C. Yung, Jerold Chun et al.|IUPHAR/BPS Guide to Pharmacology CITE|2019

Cited by 3

FTY720 requires vitamin B <sub>12</sub> -TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis

Deepa Jonnalagadda, Jerold Chun|bioRxiv (Cold Spring Harbor Laboratory)|2022

Cited by 3

Indexing the rest of 26 publications…